JP2006503081A5 - - Google Patents

Download PDF

Info

Publication number
JP2006503081A5
JP2006503081A5 JP2004543799A JP2004543799A JP2006503081A5 JP 2006503081 A5 JP2006503081 A5 JP 2006503081A5 JP 2004543799 A JP2004543799 A JP 2004543799A JP 2004543799 A JP2004543799 A JP 2004543799A JP 2006503081 A5 JP2006503081 A5 JP 2006503081A5
Authority
JP
Japan
Prior art keywords
oxazol
amine
phenyl
methoxyphenyl
ethylsulfonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004543799A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006503081A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/033317 external-priority patent/WO2004032882A2/en
Publication of JP2006503081A publication Critical patent/JP2006503081A/ja
Publication of JP2006503081A5 publication Critical patent/JP2006503081A5/ja
Pending legal-status Critical Current

Links

JP2004543799A 2002-10-10 2003-10-10 化学化合物 Pending JP2006503081A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41754802P 2002-10-10 2002-10-10
PCT/US2003/033317 WO2004032882A2 (en) 2002-10-10 2003-10-10 Chemical compounds

Publications (2)

Publication Number Publication Date
JP2006503081A JP2006503081A (ja) 2006-01-26
JP2006503081A5 true JP2006503081A5 (enExample) 2006-11-24

Family

ID=32094036

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004543799A Pending JP2006503081A (ja) 2002-10-10 2003-10-10 化学化合物

Country Status (5)

Country Link
US (1) US7189712B2 (enExample)
EP (1) EP1551813A4 (enExample)
JP (1) JP2006503081A (enExample)
AU (1) AU2003287178A1 (enExample)
WO (1) WO2004032882A2 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060111716A (ko) 2002-01-22 2006-10-27 워너-램버트 캄파니 엘엘씨 2-(피리딘-2-일아미노)-피리도[2,3-d]피리미딘-7-온
PL1648889T3 (pl) * 2003-07-11 2009-03-31 Warner Lambert Co Sól izetionian selektywnego inhibitora CDK4
CA2542909C (en) * 2003-10-23 2012-07-10 Ab Science 2-aminoaryloxazole compounds as tyrosine kinase inhibitors
EP2543376A1 (en) 2004-04-08 2013-01-09 Targegen, Inc. Benzotriazine inhibitors of kinases
WO2005102318A1 (en) * 2004-04-20 2005-11-03 Ab Science Use of c-kit inhibitors for treating hiv related diseases
JP2007538064A (ja) * 2004-05-18 2007-12-27 アブ サイエンス 化学または生物兵器に曝露された患者を処置するための肥満細胞阻害剤の使用法
PL382308A1 (pl) 2004-08-25 2007-08-20 Targegen, Inc. Związki heterocykliczne i sposoby stosowania
CA2603826C (en) * 2005-04-04 2013-03-12 Ab Science Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
CN101415683B (zh) 2006-03-31 2013-07-17 诺瓦提斯公司 新化合物
CN101460470B (zh) 2006-05-30 2011-05-18 阿斯利康(瑞典)有限公司 作为dgat1抑制剂的1,3,4-二唑衍生物
JP2010515708A (ja) * 2007-01-12 2010-05-13 アブ サイエンス 代謝拮抗薬およびチロシンキナーゼ阻害剤を用いた固形癌の併用治療
HRP20140377T2 (hr) 2007-04-16 2015-01-16 Hutchison Medipharma Enterprises Limited Derivati pirimidina
EP2231605A1 (en) * 2007-12-05 2010-09-29 Basf Se Pyridylmethyl-sulfonamide compounds
JP5662803B2 (ja) 2007-12-20 2015-02-04 アストラゼネカ アクチボラグ Dgat1阻害剤としてのカルバモイル化合物190
US8268874B2 (en) * 2008-03-03 2012-09-18 University Of Notre Dame Du Lac Anti-cancer compounds, synthesis thereof, and methods of using same
AU2010261499A1 (en) 2009-06-19 2012-01-12 Astrazeneca Ab Pyrazine carboxamides as inhibitors of DGAT1
KR101844088B1 (ko) * 2010-03-24 2018-03-30 아미텍 테러퓨틱 솔루션즈 인크 인산화효소 억제에 유용한 헤테로환 화합물
US8551992B2 (en) 2011-05-27 2013-10-08 Neosome Life Sciences, LLC Aminooxazole inhibitors of cyclin dependent kinases
CN102757400B (zh) * 2012-07-18 2014-08-06 贵州大学 2,5-取代基噁唑类衍生物及其应用
CN104744376A (zh) * 2015-03-14 2015-07-01 长沙深橙生物科技有限公司 一种2-异丙基嘧啶衍生物的制备方法
CN104803921A (zh) * 2015-03-14 2015-07-29 长沙深橙生物科技有限公司 一种苯取代嘧啶衍生物的制备方法
KR101713027B1 (ko) * 2015-12-23 2017-03-07 한국원자력의학원 페닐옥사졸계 유도체를 포함하는 암 예방 또는 치료용 조성물
KR101948555B1 (ko) * 2017-08-03 2019-02-15 한국원자력의학원 수용체 티로신 키나아제 저해제를 유효성분으로 함유하는 암 예방 또는 치료용 약학조성물
US12274703B2 (en) 2017-12-21 2025-04-15 Gliapharm Sa Compositions and methods of treatment for neurological disorders comprising a dementia
US12310967B2 (en) 2017-12-21 2025-05-27 Gliapharm Sa Compositions and methods of treatment for neurological disorders comprising motor neuron diseases
WO2019164996A1 (en) * 2018-02-21 2019-08-29 Southern Research Institute 2-aminoaryl-5-aryloxazole analogs for the treatment of neurodegenerative diseases
WO2020132378A2 (en) 2018-12-22 2020-06-25 Gliapharm Sa Compositions and methods of treatment for neurological disorders comprising depression
MX2021009570A (es) 2019-02-15 2021-09-08 Bristol Myers Squibb Co Compuestos biciclicos sustituidos como moduladores del receptor de farnesoide x.
AR118050A1 (es) 2019-02-15 2021-09-15 Bristol Myers Squibb Co Compuestos bicíclicos sustituidos como moduladores del receptor farnesoide x
US12097261B2 (en) 2021-05-07 2024-09-24 Kymera Therapeutics, Inc. CDK2 degraders and uses thereof
US12084453B2 (en) 2021-12-10 2024-09-10 Incyte Corporation Bicyclic amines as CDK12 inhibitors
KR20250144817A (ko) * 2024-03-27 2025-10-13 동국대학교 산학협력단 신규 옥사다이아졸 유도체 및 이를 포함하는 암 예방 또는 치료용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA000828B1 (ru) * 1995-12-14 2000-04-24 Мерк Энд Ко., Инк. Антагонисты гонадотропин-высвобождающего фактора
JP2002528499A (ja) * 1998-10-29 2002-09-03 ブリストル−マイヤーズ スクイブ カンパニー Impdh酵素のインヒビターであるアミノ核誘導化合物
KR100847169B1 (ko) * 2000-12-21 2008-07-17 글락소 그룹 리미티드 혈관형성 조절제로서의 피리미딘아민
WO2005004818A2 (en) * 2003-07-09 2005-01-20 Imclone Systems Incorporated Heterocyclic compounds and their use as anticancer agents

Similar Documents

Publication Publication Date Title
JP2006503081A5 (enExample)
RU2492167C2 (ru) Производные аминотриазола в качестве агонистов alх
RU2489426C2 (ru) Производные аминопиразола
JP2010533158A5 (enExample)
JP2007516173A5 (enExample)
JP2015533157A5 (enExample)
JP2019517455A5 (enExample)
JP2009537543A5 (enExample)
JP2013519680A5 (enExample)
JP2005538955A5 (enExample)
JP2007530690A5 (enExample)
IL303196A (en) Heteroaryl-substituted pyridines and methods of use
RU2012132692A (ru) Новые ингибиторы s-нитрозоглутатионредуктазы
RU2012116207A (ru) Производные индола в качестве модуляторов crac
RU2006133909A (ru) Производные азабицикло {3. 1. 0}гексана, применимые в качестве модуляторов допаминовых рецепторов d3
JP2007523208A5 (enExample)
RU2004121029A (ru) Производные пиримидина в качестве модуляторов рецептора инсулинподобного фактора роста 1 (igf-1)
JP2007508346A5 (enExample)
JP2010540452A5 (enExample)
JP2006524686A5 (enExample)
JP2009525340A5 (enExample)
JP2018507234A5 (enExample)
RU2016111138A (ru) Гетероциклические соединения и способы их применения
RU2332996C2 (ru) Производные гидразонпиразола и их применение в качестве лекарственного средства
RU2016129018A (ru) Производные оксиндола, их получение и терапевтическое применение при лечении заболеваний, связанных с амрк